Increased pulmonary blood flow does not alter surfactant protein gene expression in lambs within the first week of life

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 286, Issue 6 30-6, 2004, Pages

  Lee, Jae W ^a   Ovadia, Boaz ^b   Azakie, Anthony ^b   Salas, Sonia ^b   Goerke, Jon ^a,b   Fineman, Jeffrey R ^a,b   Gutierrez, Jorge A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Congenital heart disease

Indexed keywords

SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL GRAFT; CONGENITAL HEART DISEASE; CONTROLLED STUDY; GENE EXPRESSION; LAMB; LUNG BLOOD FLOW; LUNG COMPLIANCE; MORBIDITY; NEWBORN; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN CONTENT; PULMONARY HYPERTENSION; SHUNTING;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ENDOTHELIN-1; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; NITRIC OXIDE; PHOSPHATIDYLCHOLINES; PREGNANCY; PULMONARY CIRCULATION; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; RNA, MESSENGER; SHEEP; VASCULAR RESISTANCE;

EID: 2442692957     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00271.2003     Document Type: Article

References (60)

1. Altman PL and Dittmer DS. Respiration and circulation. In: FASEB Biological Handbook. Bethesda. MD: FASEB, 1971.
2. Awasthi S, Coalson JJ, Yoder BA, Crouch E, and King RJ. Deficiencies in lung surfactant proteins A and D are associated with lung infection in very premature neonatal baboons. Am J Respir Crit Care Med 163: 389-397, 2001.
3. Ayad O and Wong HR. Nitric oxide decreases surfactant protein A gene expression in H441 cells. Crit Care Med 26: 1277-1282, 1998.
4. Bailey TC, Cavanagh C, Mehta S, Lewis JF, and Veldhuizen RA. Sepsis and hyperoxia effects on the pulmonary surfactant system in wild type and iNOS knockout mice. Eur Respir J 20: 177-182, 2002.
5. Bando K, Turrentine MW, Sharp TG, Sekine Y, Aufiero TX, Sun K, Sekine E, and Brown JW. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management. J Thorac Cardiovasc Surg 112: 1600-1609, 1996.
6. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 234: 466-468, 1959.
7. Berisha HI, Pakbaz H, Absood A, and Said SI. Nitric oxide as a mediator of oxidant lung injury due to paraquat. Proc Natl Acad Sci USA 91: 7445-7449, 1994.
8. Black SM, Bekker JM, Johengen MJ, Parry AJ, Soifer SJ, and Fineman JR. Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 47: 97-106, 2000.
9. Black SM, Fineman JR, Steinhorn RH, Bristow J, and Soifer SJ. Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Heart Circ Physiol 275: H1643-H1651, 1998.
10. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
11. Bose CI, Richardson P, Wood B, Gonzalez F, and King J. Phospholipids in tracheal effluent from infants with severe respiratory distress syndrome. Am J Perinatol 1: 208-213, 1984.
12. Burrows FA, Klinck JR, Rabinovitch M, and Bohn DJ. Pulmonary hypertension in children: perioperative management. Can Anaesth Soc J 33: 5606-5628, 1986.
13. Castaneda AR, Mayer JE Jr, Jonas RA, Lock JE, Wessel DL, and Hickey PR The neonate with critical congenital heart disease: repair - a surgical challenge. J Thorac Cardiovasc Surg 98: 869-875, 1989.
14. Chang AC, Hanley FL, Lock JE, Castaneda AR, and Wessel DL. Management and outcome of low birth weight neonates with congenital heart disease. J Pediatr 124: 461-466, 1994.
15. Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, and Whitsett JA. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 92: 7794-7798, 1995.
16. Clements JA. Lung surfactant: a personal perspective. Annu Rev Physiol 59: 1-21, 1997.
17. Cogo PE, Zimmermann LJI, Pesavento R, Sacchetto E, Burighel A, Rosso F, Badon T, Verlato G, and Carnielli VP. Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia. Crit Care Med 31: 1532-1538, 2003.
18. Crouch E and Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 63: 521-554, 2001.
19. Cruz WS, Moxley MA, Corbett JA, and Longmore WJ. Inhibition of nitric oxide synthase attenuates NNMU-induced alveolar injury in vivo. Am J Physiol Lung Cell Mol Physiol 273: L1167-L1173, 1997.
20. Diamond SL, Sharefkin JB, Dieffenbach C, Frasier-Scott KL, McIntire V, and Eskin SG. Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress. J Cell Physiol 143: 364-371, 1990.
21. Dinger J, Topfer A, Schaller P, and Schwarze R. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome. Eur J Pediatr 161: 485-490, 2002.
22. Grigg J, Kleinert S, Woods RL, Thomas CJ, Vervaart P, Wilkinson JL, and Robertson CF. Alveolar epithelial lining fluid cellularity, protein and endothelin-1 in children with congenital heart disease. Eur Respir J 9: 1381-1388, 1996.
23. Gutierrez JA, Ertsey R, Seavo LM, Collins E, and Dobbs LG. Mechanical distention modulates alveolar epithelial cell phenotypic expression by transcriptional regulation. Am J Respir Cell Mol Biol 21: 223-229, 1999.
24. Gutierrez JA, Gonzalez RF, and Dobbs LG. Mechanical distention modulates pulmonary alveolar epithelial expression in vitro. Am J Physiol Lung Cell Mol Physiol 274: L196-L202, 1998.
25. Gutierrez JA, Parry AJ, McMullan DM, Chapin CJ, and Fineman JR. Decreased surfactant proteins in lambs with pulmonary hypertension secondary to increased blood flow. Am J Physiol Lung Cell Mol Physiol 281: L1264-L1270, 2001.
26. Haddad IY, Crow JP, Hu P, Ye Y, Beckman J, and Matalon S. Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Am J Physiol Lung Cell Mol Physiol 267: L242-L249, 1994.
27. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, and Matalon S. Mechanisms of peroxynitrite-induced injury to pulmonary surfactant. Am J Physiol Lung Cell Mol Physiol 265: L555-L564, 1993.
28. Haddad IY, Zhu S, Crow J, Barefield E, Gadilhe, and Matalon S. Inhibition of alveolar type II cell ATP and surfactant synthesis by nitric oxide. Am J Physiol Lung Cell Mol Physiol 270: L898-L906, 1996.
29. Haddad IY, Zhu S, Ischiropoulos H, and Matalon S. Nitration of surfactant protein A results in decreased ability to aggregate lipids. Am J Physiol Lung Cell Mol Physiol 270: L281-L288, 1996.
30. Hallman M and Bry K. Nitric oxide and surfactant. Semin Perinatol 20: 173-185, 1996.
31. Hallman M, Bry K, and Lappalainen U. A mechanism of nitric oxide-induced surfactant dysfunction. J Appl Physiol 80: 2035-2043, 1996.
32. Hallman M, Haataja R, and Marttila R. Surfactant proteins and genetic predisposition to respiratory distress syndrome. Semin Perinatol 26: 450-460, 2002.
33. Hallman M, Waffarn F, Bry K, Turbow R, Kleinman MT, Mautz WJ, Rasmussen RE, Bhalla DK, and Phalen RF. Surfactant dysfunction after inhalation of nitric oxide. J Appl Physiol 80: 2026-2034, 1996.
34. Hoffman JIE, Rudolph AM, and Heymann MA. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation 64: 873-877, 1981.
35. Ischiropoulos H, al-Mehdi AB, and Fisher AB. Reactive species in ischemic rat lung injury: contribution of peroxynitrite. Am J Physiol Lung Cell Mol Physiol 269: L158-L164, 1995.
36. Ishikawa S, Miyauchi T, Ueno H, Ushinohama H, Sagawa K, Fusazaki N, Sunagawa H, Honda S, Sakai S, Yamaguchi I, Goto K, and Sugishita Y. Influence of pulmonary blood pressure and flow on endothelin-1 production in humans. J Cardiovasc Pharmacol 26: S429-S433, 1995.
37. Kazzi SNJ, Schurch S, McLaughlin KL, Romero R, and Janisse J. Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop bronchopulmonary dysplasia. Acta Paediatr 89: 1218-1225, 2000.
38. Lang JD, McArdle PJ, O'Reilly PJ, and Matalon S. Oxidant-antioxidant balance in acute lung injury. Chest 122: 314S-320S, 2002.
39. Laussen PC. Neonates with congenital heart disease. Curr Opin Pediatr 13: 220-226, 2001.
40. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, and Korfhagen TR. Surfactant protein A-deficit mice are susceptible to group B streptococcal infection. J Immunol 158: 4336-4340, 1997.
41. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, and Korfhagen TR. Surfactant protein A-deficit mice are susceptible to pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 19: 700-708, 1998.
42. LeVine AM, Whitsett JA, Gwozdz JA, Richardson TR, Fisher JH, Burhans MS, and Korfhagen TR. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 165: 3934-3940, 2000.
43. Matalon S, DeMarco V, Haddad IY, Myles C, Skimming JW, Schurch S, Cheng S, and Cassin S. Inhaled nitric oxide injures the pulmonary surfactant system of lambs in vivo. Am J Physiol Lung Cell Mol Physiol 270: L273-L280, 1996.
44. McDowell SA, Gammon K, Zingarelli B, Bachurski CJ, Aronow BJ, Prows DR, and Leikauf GD. Inhibition of nitric oxide restores surfactant gene expression following nickel-induced acute lung injury. Am J Respir Cell Mol Biol 28: 188-198, 2003.
45. 2 as markers of altered surfactant metabolism. Lung 172: 61-72, 1994.
46. Nagel T, Resnick N, Atkinson WJ, Dewey CF, and Gimbrone MA. Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest 94: 885-891, 1994.
47. Ovadia B, Reinhartz O, Fitzgerald R, Bekker JM, Johengen MJ, Azakie A, Thelitz S, Black SM, and Fineman JR. Alterations in ET-1, not nitric oxide, in 1-week-old lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 284: H480-H490, 2003.
48. Piedboeuf B, Laberge JM, Ghitulescu G, Gamache M, Petrov P, Belanger S, Chen M, Hashim E, and Possmayer F. Deleterious effect of tracheal obstruction on type II pneumocytes in fetal sheep. Pediatr Res 41: 473-479, 1997.
49. Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, and Reid LM. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 58: 1107-1122, 1978.
50. Radomski A, Sawicki G, Olson DM, and Radomski MW. The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats. Br J Pharmacol 125: 1455-1462, 1998.
51. Reddy VM, McElhinney DB, Sagrado T, Parry AJ, Teitel DF, and Hanley FL. Results of 102 cases of complete repair of congenital heart defects in patients weighing 700 to 2500 grams. J Thorac Cardiovasc Surg 117: 324-331, 1999.
52. Reddy VM, Meyrick B, Wong J, Khoor A, Liddicoat JR, Hanley FL, and Fineman JR. In utero placement of aortopulmonary shunts. A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 92: 606-613, 1995.
53. Setaro F and Morley CG. A modified fluorometric method for the determination of microgram quantities of DNA from cell or tissue culture. Anal Biochem 71: 313-317, 1976.
54. Shelley SA, Kovacevic M, Paciga JE, and Balis JU. Sequential changes of surfactant phosphatidylcholine in hyaline-membrane disease of the newborn. N Engl J Med 300: 112-116, 1979.
55. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
56. Stuart RB, Ovadia B, Suzara VV, Ross PA, Thelitz S, Fineman JR, and Gutierrez JA. Inhaled nitric oxide increases surfactant protein gene expression in the intact lamb. Am J Physiol Lung Cell Mol Physiol 285: L628-L633, 2003.
57. Touchstone JC, Chen JC, and Beaver KM. Improved separation of phospholipids in thin layer chromatography. Lipids 15: 61-62, 1979.
58. Wang LF, Patel M, Razavi HM, Weicker S, Joseph MG, McCormack DG, and Mehta S. Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis. Am J Respir Crit Care Med 165: 1634-1639, 2002.
59. Wang PM, Fujita E, and Bhattacharya J. Mechanotransduction in the lung vascular regulation of type II cell exocytosis. Am J Physiol Lung Cell Mol Physiol 282: L912-L916, 2002.
60. Zou MH, Shi C, and Cohen RA. Oxidation of zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109: 817-826, 2002.